Literature DB >> 23933175

E. coli and colon cancer: is mutY a culprit?

Abdul Arif Khan1, Phillip Cash.   

Abstract

The recent demonstration of a role of Escherichia coli in the development of invasive carcinoma in mice ushers a new era of bacterial involvement in cancer etiology. It has been shown previously that the colonic mucosa of colorectal carcinoma (CRC) is exclusively colonized by intracellular E. coli instead of extracellular form found in normal colonic mucosa. Surprisingly, the DNA repair gene MUTYH, which is a homologue of the E. coli gene mutY, is responsible for CRC. The current paper discusses the potential role of mutY in CRC etiology and concludes that research in this area can bring together the diverse threads of the CRC etiology puzzle.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Carcinogenesis; Chronic inflammation; E. coli; MUTYH; mutY

Mesh:

Substances:

Year:  2013        PMID: 23933175     DOI: 10.1016/j.canlet.2013.08.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Deciphering the involvement of iron targets in colorectal cancer: a network biology approach.

Authors:  Abdul Arif Khan; Mohd Tashfeen Ashraf; Fahad M Aldakheel; Ayca Sayi Yazgan; Rana Zaidi
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

Review 2.  Modulators affecting the immune dialogue between human immune and colon cancer cells.

Authors:  Meir Djaldetti; Hanna Bessler
Journal:  World J Gastrointest Oncol       Date:  2014-05-15

Review 3.  Microbial imbalance and intestinal pathologies: connections and contributions.

Authors:  Ye Yang; Christian Jobin
Journal:  Dis Model Mech       Date:  2014-10       Impact factor: 5.758

Review 4.  A clinical perspective on the role of chronic inflammation in gastrointestinal cancer.

Authors:  Sebastian Rasch; Hana Algül
Journal:  Clin Exp Gastroenterol       Date:  2014-08-11

Review 5.  Microbiota and cancer: current understanding and mechanistic implications.

Authors:  A A Khan; A T Sirsat; H Singh; P Cash
Journal:  Clin Transl Oncol       Date:  2021-08-13       Impact factor: 3.405

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.